Search research articles
Contact Us
Filters
Showing results (101-110 of 208) with videos related to
Page
of 21
Sort By:
Blood
|
August 17, 2006
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi, Todd A Alonzo, Derek L Stirewalt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia
Susan O'Brien, Ellin Berman, Joseph O Moore, et al.
The New England Journal of Medicine
|
October 10, 2003
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
Tim P Hughes, Jaspal Kaeda, Susan Branford, et al.
Scientific Reports
|
April 7, 2022
AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker
Deepti Reddi, Brandon W Seaton, David Woolston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
Matthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Blood
|
April 15, 2016
Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots
Olga Sala Torra, Lan Beppu, Jordan L Smith, et al.
Angewandte Chemie (International Ed. in English)
|
July 14, 2018
A Self-Digitization Dielectrophoretic (SD-DEP) Chip for High-Efficiency Single-Cell Capture, On-Demand Compartmentalization, and Downstream Nucleic Acid Analysis
Yuling Qin, Li Wu, Thomas Schneider, et al.
Blood
|
December 16, 2006
Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia
Olga Sala-Torra, Holly M Gundacker, Derek L Stirewalt, et al.
Blood
|
September 26, 2009
Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations
Martin C Müller, Jorge E Cortes, Dong-Wook Kim, et al.
American Journal of Hematology
|
October 23, 2019
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia
Elizabeth F Krakow, Boglarka Gyurkocza, Barry E Storer, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 208) with videos related to
Sort By:
Page
of 21
Blood
|
August 17, 2006
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi, Todd A Alonzo, Derek L Stirewalt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia
Susan O'Brien, Ellin Berman, Joseph O Moore, et al.
The New England Journal of Medicine
|
October 10, 2003
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
Tim P Hughes, Jaspal Kaeda, Susan Branford, et al.
Scientific Reports
|
April 7, 2022
AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker
Deepti Reddi, Brandon W Seaton, David Woolston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
Matthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Blood
|
April 15, 2016
Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots
Olga Sala Torra, Lan Beppu, Jordan L Smith, et al.
Angewandte Chemie (International Ed. in English)
|
July 14, 2018
A Self-Digitization Dielectrophoretic (SD-DEP) Chip for High-Efficiency Single-Cell Capture, On-Demand Compartmentalization, and Downstream Nucleic Acid Analysis
Yuling Qin, Li Wu, Thomas Schneider, et al.
Blood
|
December 16, 2006
Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia
Olga Sala-Torra, Holly M Gundacker, Derek L Stirewalt, et al.
Blood
|
September 26, 2009
Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations
Martin C Müller, Jorge E Cortes, Dong-Wook Kim, et al.
American Journal of Hematology
|
October 23, 2019
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia
Elizabeth F Krakow, Boglarka Gyurkocza, Barry E Storer, et al.
Page
of 21